BioPass Pharma Overview
BioPass Pharma is developing a revolutionary formulation intended for the treatment of brain or CNS diseases utilizing its patented novel technology, which is designed to deliver molecules directly into the brain by bypassing the BBB. Its novel nasal formulation offers short onset of a non-invasive, painless, easily administered treatment, avoiding gastrointestinal and hepatic presystemic metabolism. BioPass Pharma has secured exclusive rights for this technology from the Hebrew University of Jerusalem.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
11
Employees: 1-10
Web & Social Links
Locations
Petah Tikva, Israel
Photos & Videos
No files yet
BioPass Pharma Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcarePatientsCore Technology
Materials & SubstancesNanomaterialsTags (7)
cns-disordersdrug-discoverytargeted-therapydrug-deliverynon-invasivepharmaceuticalsnanotechnologyGeographic Markets
GlobalBioPass Pharma Financials
BioPass Pharma Lifecycle
BioPass Pharma News
0 articlesNo news articles.
BioPass Pharma Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 11 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
BioPass Pharma Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 75/100 |
| Missing | sector, homepage, video or image, funding rounds, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516484375 |
| Phone | +972-54-5588089|+972-50-9051575 |
| Creator | Shlomi Zandberg |
| Creator email | shlomi@sync.co.il |
| Last update | 2024-09-02T00:00:00.000Z |
| Created | 2024-09-02T00:00:00.000Z |
| Claimed | Yes |